Molecules / Everolimus / China

Everolimus API manufacturers in China

CAS 159351-69-6 ATC L01XE10 Updated 9 July 2026
8
China-based manufacturers with an active filing of 12 worldwide
Showing 4 of 8 China-based manufacturers This list is ranked on evidence. Placement cannot be purchased.

Ranked China-based API manufacturers

02

Chengdu Yacht Biotechnology

China
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds 2 active US DMFs for everolimus, filing since 2015.

US DMF
2 active
CEP
None on file
Last FDA inspection
Not established
GMP recognised in
Not established
How this listing is sourced FDA, List of Drug Master Files
View profile
04

Hisun Pharmaceutical

China
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds one valid CEP for everolimus, filing since 2025.

US DMF
None on file
CEP
1 valid
Last FDA inspection
Not established
GMP recognised in
Not established
How this listing is sourced EDQM certificate database
View profile

4 more manufacturers in China hold filings for everolimus

The names are listed below. The filings, inspection history and GMP certificates behind each one are available with a free account.

BrightGene Bio-Medical TechnologyChengdu Yacht BiotechnologyHangzhou Huadong Medicine Group Kangrun PharmaceuticalHisun Pharmaceutical
Open the full list with a free account

How this list is built

This page filters the worldwide Everolimus manufacturer list to companies based in China. The order is set by active filings weighted by regulator, inspection outcomes and their recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags. Read the full method.

Map everolimus for your markets

Tell us which markets you need to file in. These suppliers come back tiered for those markets, with the price corridor and an RFI sheet.

Start for free
No sales call.

All Everolimus manufacturers

Worldwide 12 India 5